These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2498447)

  • 21. The association between preovulatory serum 17 beta-estradiol pattern and conception in human menopausal gonadotropin-human chorionic gonadotropin stimulation.
    Laufer N; DeCherney AH; Tarlatzis BC; Naftolin F
    Fertil Steril; 1986 Jul; 46(1):73-6. PubMed ID: 3087791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women.
    Westergaard LG; Erb K; Laursen S; Rasmussen PE; Rex S
    Hum Reprod; 1996 Jun; 11(6):1209-13. PubMed ID: 8671425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum progesterone levels in women treated with human menopausal gonadotropin and human chorionic gonadotropin for in vitro fertilization.
    Huang KE; Muechler EK; Schwarz KR; Goggin M; Graham MC
    Fertil Steril; 1986 Nov; 46(5):903-6. PubMed ID: 3096786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of human menopausal gonadotropin and follicle-stimulating hormone with gonadotropin-releasing hormone agonist desensitization for controlled ovarian hyperstimulation in in vitro fertilization.
    Yang TS; Wang BC; Chang SP; Ng HT
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jun; 55(6):452-6. PubMed ID: 7634183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization.
    Droesch K; Muasher SJ; Brzyski RG; Jones GS; Simonetti S; Liu HC; Rosenwaks Z
    Fertil Steril; 1989 Feb; 51(2):292-7. PubMed ID: 2492234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The combination of follicle-stimulating hormone and human menopausal gonadotropin for the induction of multiple follicular maturation for in vitro fertilization.
    Muasher SJ; Garcia JE; Rosenwaks Z
    Fertil Steril; 1985 Jul; 44(1):62-9. PubMed ID: 3924669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of consecutive in vitro fertilization cycles among patients treated with follicle-stimulating hormone (FSH) and human menopausal gonadotropin versus FSH alone.
    Sills ES; Schattman GL; Veeck LL; Liu HC; Prasad M; Rosenwaks Z
    Fertil Steril; 1998 May; 69(5):831-5. PubMed ID: 9591488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monitoring gonadotropin-stimulated cycles for in vitro fertilization and embryo transfer.
    Kreiner D; Muasher SJ; Acosta AA; Jones GS; Liu HC; Rosenwaks Z
    J In Vitro Fert Embryo Transf; 1988 Aug; 5(4):230-3. PubMed ID: 3141535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pregnancy rate and ovarian hyperstimulation after luteal human chorionic gonadotropin in in vitro fertilization stimulated with gonadotropin-releasing hormone analog and menotropins.
    Herman A; Ron-El R; Golan A; Raziel A; Soffer Y; Caspi E
    Fertil Steril; 1990 Jan; 53(1):92-6. PubMed ID: 2104811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human urinary follicle-stimulating hormone and human menopausal gonadotropin in induction of multiple follicle growth and ovulation.
    Venturoli S; Orsini LF; Paradisi R; Fabbri R; Porcu E; Magrini O; Flamigni C
    Fertil Steril; 1986 Jan; 45(1):30-5. PubMed ID: 3080344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlled ovarian hyperstimulation for in vitro fertilization using buserelin and gonadotropin in patients with previous failed cycles.
    Loong EP; Tam PP; Chiu TT; Chan MY; Panesar NS; Lau J
    Asia Oceania J Obstet Gynaecol; 1990 Dec; 16(4):297-300. PubMed ID: 2129187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostaglandin F2 alpha, progesterone and estradiol concentrations in human follicular fluid and their relation to success of in vitro fertilization.
    Suchanek E; Simunic V; Macas E; Kopjar B; Grizelj V
    Eur J Obstet Gynecol Reprod Biol; 1988 Aug; 28(4):331-9. PubMed ID: 3139478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Equivalency of human menopausal gonadotropin and follicle-stimulating hormone stimulation after gonadotropin-releasing hormone agonist suppression.
    Edelstein MC; Brzyski RG; Jones GS; Simonetti S; Muasher SJ
    Fertil Steril; 1990 Jan; 53(1):103-6. PubMed ID: 2104806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of the flare-up protocol with high dose human follicle stimulating hormone and human menopausal gonadotropins for in vitro fertilization in poor responders.
    Padilla SL; Dugan K; Maruschak V; Shalika S; Smith RD
    Fertil Steril; 1996 Apr; 65(4):796-9. PubMed ID: 8654641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of hMG and/or FSH for multiple follicle development.
    Rosenwaks Z; Muasher SJ; Acosta AA
    Clin Obstet Gynecol; 1986 Mar; 29(1):148-57. PubMed ID: 3082552
    [No Abstract]   [Full Text] [Related]  

  • 36. The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome.
    Muasher SJ; Oehninger S; Simonetti S; Matta J; Ellis LM; Liu HC; Jones GS; Rosenwaks Z
    Fertil Steril; 1988 Aug; 50(2):298-307. PubMed ID: 3135206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Follicular atresia associated with concurrent initiation of gonadotropin-releasing hormone agonist and follicle-stimulating hormone for oocyte recruitment.
    Brzyski RG; Muasher SJ; Droesch K; Simonetti S; Jones GS; Rosenwaks Z
    Fertil Steril; 1988 Dec; 50(6):917-21. PubMed ID: 3144467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clomiphene citrate and hMG: an alternative stimulation protocol for selected failed in vitro fertilization patients.
    Benadiva CA; Davis O; Kligman I; Liu HC; Rosenwaks Z
    J Assist Reprod Genet; 1995 Jan; 12(1):8-12. PubMed ID: 7580013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of estradiol/follicle and estradiol/oocyte ratios on the outcome of controlled ovarian stimulation for in vitro fertilization.
    Orvieto R; Zohav E; Scharf S; Rabinson J; Meltcer S; Anteby EY; Homburg R
    Gynecol Endocrinol; 2007 Feb; 23(2):72-5. PubMed ID: 17454155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells.
    Minaretzis D; Alper MM; Oskowitz SP; Lobel SM; Mortola JF; Pavlou SN
    Am J Obstet Gynecol; 1995 May; 172(5):1518-25. PubMed ID: 7755066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.